A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Uterine Cancer; Cervix Uteri Nos; Gestational Trophoblastic Disease

Treatments: Behavioral: questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT00706875

08-040

Details and patient eligibility

About

The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD survivors' health and quality of life.

We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.

Enrollment: 59 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pathology confirmed GTD by MSKCC
• Sufficient proficiency in the English language to respond to quality of life surveys
• Age ≥ 18 years
• Benign or malignant disease
• Treated with surgery and/or chemotherapy or observation

Exclusion criteria

• None

Trial design

59 participants in 2 patient groups

1

Description:

30 patients survived GTD post treatment for 0 - 5 years.

Treatment:

Behavioral: questionnaire

Behavioral: questionnaire

2

Description:

30 patients survived GTD post treatment 6 - 10+ years.

Treatment:

Behavioral: questionnaire

Behavioral: questionnaire